PHARMAPRIM SAS
Import activity
2018 to 2026Is PHARMAPRIM SAS on a US restricted-party list?
Checked against 13 Commerce, State and Treasury lists, refreshed daily.
What PHARMAPRIM SAS imports
share of the ranked product mix| HS code | Product | Share | Ranked |
|---|---|---|---|
| 2941909000 | Antibiotics, in heading no. 2941 | 31.0% | #1 · 5 yrs |
| 2933599000 | Heterocyclic compounds, containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) in 2933.5 | 21.1% | #1 · 4 yrs |
| 2941400000 | Antibiotics, chloramphenicol and its derivatives, salts thereof | 9.9% | #3 · 3 yrs |
| 2935909000 | Sulphonamides, in heading no. 2935 | 8.5% | #3 · 2 yrs |
| 2933699000 | Heterocyclic compounds, containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine | 7.0% | #1 · 2018 |
| 2941301000 | Antibiotics, tetracyclines and their derivatives, salts thereof | 7.0% | #1 · 2023 |
| 2933290000 | Heterocyclic compounds, with nitrogen hetero-atom(s) only, containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives | 5.6% | #2 · 2022 |
| 2941101000 | Antibiotics, penicillins and their derivatives with a penicillanic acid structure, salts thereof | 5.6% | #4 · 2 yrs |
| 2941302000 | Antibiotics, tetracyclines and their derivatives, salts thereof | 2.8% | #4 · 2024 |
| 2921590000 | Amine-function compounds, aromatic polyamines and their derivatives, other than item no. 2921.51 | 1.4% | #5 · 2025 |
Share folds the directory's yearly top-five ranks across every year on record (a #1 counts five times a #5); the source publishes ranks, not per-product volumes.
Largest importers of antibiotics
ranked by declared CIF, all years| # | Company | Active | Products | Declarations | Declared value |
|---|---|---|---|---|---|
| 1 | PROCAPS S.A | 5 yr | 5 | 1,073 | $75M |
| 2 | LABORATORIO FRANCO COLOMBIANO LAFRANCOL S.A.S. | 3 yr | 5 | 551 | $53.3M |
| 3 | VALLECILLA B Y VALLECILLA M Y CIA S C A CARVAL DE COLOMBIA | 10 yr | 5 | 861 | $30.9M |
| 4 | ALURA ANIMAL HEALTH & NUTRITION SAS | 10 yr | 5 | 150 | $20.6M |
| 5 | LABORATORIO PROFESIONAL FARMACEUTICO S.A.S. PERO PODRA IGUAL | 3 yr | 5 | 174 | $17.7M |
| 6 | LABORATORIOS LA SANTE S.A. | 10 yr | 5 | 518 | $16.8M |
| 7 | VITALIS S.A. C.I. | 10 yr | 5 | 358 | $15.2M |
| 8 | LABORATORIOS AUROFARMA S.A.S | 10 yr | 5 | 232 | $14M |
| 9 | VICAR FARMACEUTICA S A | 10 yr | 5 | 278 | $9.4M |
| 10 | SYNTOFARMA S A | 10 yr | 5 | 153 | $9.2M |
Who supplies PHARMAPRIM SAS?
Look up the exporters shipping to PHARMAPRIM SAS, with what they ship and how, in the app.
Decision makers at PHARMAPRIM SAS
Purchasing, import and management contacts with titles and LinkedIn profiles, revealed in the platform.
Unit prices, the complete declaration history, the LinkedIn decision-maker finder and the AI Analyst for PHARMAPRIM SAS.
Common questions
What does PHARMAPRIM SAS import?
Colombia's customs importer directory (DIAN) list antibiotics, heterocyclic compounds and sulphonamides as PHARMAPRIM SAS's principal imports (ranked by HS subheading, 10 products on record).
How much does PHARMAPRIM SAS import?
$192.9k of declared CIF value in 2025 across 21 import declarations (+108% versus 2024); $405.9k in total between 2018 to 2026.
Where does PHARMAPRIM SAS source from?
Colombia's importer directory publishes each importer's products, declared value, net weight and declaration count, but not its origin countries or suppliers.
Who else imports antibiotics in Colombia?
PROCAPS S.A, LABORATORIO FRANCO COLOMBIANO LAFRANCOL S.A.S. and VALLECILLA B Y VALLECILLA M Y CIA S C A CARVAL DE COLOMBIA rank among the largest importers of antibiotics (HS 2941) in Colombia, out of 72 importers on record in 2025.
Where does this data come from?
Directly from Colombia's customs importer directory (DIAN). Exsigo ingests the official records; nothing here is scraped from directories or estimated.